Skip to main content
Home
language-selector-globe Czech Republic | en
Choose Location
language-selector-globe Czech Republic |
CzechEnglish
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe Czech Republic
Choose Location
language-selector-globeCzech Republic
CzechEnglish
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in the Czech Republic 
      • Strategy 
      • Diversity and inclusion 
      • People and culture 
      • Products 
      • Country leadership team 
      • Our mission and vision 
      • Innovative medicines 
      • Contact 
      Novartis Česká republika About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Our patient portals for Czech Republic 
      • Products 
      • Adverse event reporting 
      • Provision of gifts and grants 
      Babička s vnučkou v objetí Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Products 
      • Novartis pipeline 
      • Adverse event reporting 
      • Novartis clinical trials 
        • Clinical trials in Czech Republic 
      • VPOIS 
      • Expert information 
      Vědec se dívá do mikroskopu Healthcare Professionals
    • Research and development 
      • Research and development in Czech Republic 
      Vědkyně v laboratoři Research and development
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Ethical behavior 
      • Whistleblow line 
      Ruka na rozpukané vyprahlé hlíně ESG
    • News 
      • News archive 
      • Stories 
      • Media library 
      • Media contacts 
      Diskutující lidé s notebooky nad odbornými články News
    • Careers 
      • Career search 
      • Meet the teams 
      • Personal growth 
      • Early talent 
      • How we work 
      • Leadership trainee program 
      • Well-being 
      • Diversity and inclusion 
      • Awards and recognition 
      Usmívající se žena v posluchárně Careers
    • Coronavirus 
      Částice viru SARS CoV 2 na snímku z elektronového mikroskopu. Coronavirus
    Female scientist in laboratory Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
MR Wuhu (Anhui Province) China International Innovative Medicines Sales Jul 26, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
MR Beijing (Beijing) China International Innovative Medicines Sales Sep 01, 2024
MR Baise (Guangxi Province) China International Innovative Medicines Sales Sep 04, 2024
MR Xiamen (Fujian Province) China International Innovative Medicines Sales Sep 10, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
Medical Representative - CVRM Mapletree Business City (MBC) Singapore International Innovative Medicines Sales Sep 02, 2024
Manager-Retail National Key Account Changsha (Hunan Province) China International Innovative Medicines Sales Jul 04, 2024
Key Account Manager, Haematology - South West Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Aug 21, 2024
Key Account Manager , Haematology - Yorkshire, East Midlands, Northamptonshire. Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Sep 03, 2024
Key Account Manager Novokuznetsk Russian Fed. International Innovative Medicines Sales Sep 25, 2024
KAM/Senior KAM - Oncology - North London Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Sep 20, 2024
Job Posting Title Sales Representative (w/m/d), TA: Onkologie, Gebiet: Österreich West Vienna Austria International Innovative Medicines Sales Oct 07, 2024
Hematology Area Manager Novosibirsk Russian Fed. International Innovative Medicines Sales Oct 22, 2024
Hematology Area Manager Moscow (City) Russian Fed. International Innovative Medicines Sales Oct 22, 2024
First Line Manager / District Manager Xiamen (Fujian Province) China International Innovative Medicines Sales Jun 19, 2024
First Line Manager / District Manager Changchun (Jilin Province) China International Innovative Medicines Sales Oct 09, 2024
First Line Manager / District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Oct 09, 2024
Field Sales Leader, Oncology (Scotland, Northern Ireland & North East England) Field Force (Scotland) United Kingdom International Innovative Medicines Sales Sep 27, 2024
Field Product Specialist - Hue Vietnam Vietnam International Innovative Medicines Sales Oct 16, 2024
Field Product Specialist - Cardivovascular - HCM Vietnam Vietnam International Innovative Medicines Sales Oct 20, 2024
Field Product Specialist - Cardiovascular- Ha Noi Vietnam Vietnam International Innovative Medicines Sales Oct 20, 2024
Expert Développement des Compétences - Visite Médicale H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Sales Oct 11, 2024
Executive Product Specialist Quanzhou (Fujian Province) China International Innovative Medicines Sales Sep 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Sep 24, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 16
  • › Next page

Novartis Czech Republic

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
  • Adverse event reporting
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis websites
  • Global
Footer Bottom
© 2024 Novartis s.r.o
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Czech Republic